Malatesta Michael F 4
4 · SELECT MEDICAL HOLDINGS CORP · Filed Jul 1, 2026
Research Summary
AI-generated summary of this filing
SELECT MEDICAL (SEM) CFO Michael Malatesta Disposes 238,057 Shares
What Happened
- Michael F. Malatesta, Chief Financial Officer of Select Medical Holdings Corp (SEM), reported the disposition of 238,057 SEM shares on June 30, 2026. The transaction is coded as "Other acquisition or disposition (J)" and shows a $0.00 per-share price (total proceeds $0), indicating the shares were transferred as part of a merger transaction rather than sold for cash.
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-01 (covers the 6/30/2026 reporting period).
- Shares disposed: 238,057; reported price: $0.00; reported value: $0.
- Transaction code: J — made in connection with a merger or acquisition.
- Footnotes: F1/F2 state the disposition occurred under the Merger Agreement (filed 3/3/2026). Immediately prior to the merger's effective time, Malatesta contributed 79,723 common shares and 158,334 restricted shares to Parent, received Parent common shares, which were then exchanged for interests in Stallion Group Parent, LP.
- Post-transaction holding: The filing indicates these 238,057 SEM shares were converted/exchanged under the merger; the report implies no remaining SEM common shares from this lot.
Context
- This was a merger-related conversion/exchange, not an open-market sale; no cash changed hands on the reported disposition, so it should not be read as a routine insider sell signal. The reporting person received ownership interests in the acquiring parent (Stallion Group Parent, LP) as described in the footnotes.
Insider Transaction Report
Form 4Exit
Malatesta Michael F
CHIEF FINANCIAL OFFICER
Transactions
- Other
Common Stock
[F1][F2]2026-06-30−238,057→ 0 total
Footnotes (2)
- [F1]This Form 4 reports securities disposed of under the Agreement and Plan of Merger (the "Merger Agreement"), entered into on March 2, 2026, by and among the Issuer, Stallion Intermediate Corporation ("Parent"), and Stallion MergerSub Corporation (filed as Exhibit 2.1 to the Form 8-K filed with the Securities and Exchange Commission on March 3, 2026).
- [F2]Immediately prior to the effective time of the merger, the Reporting Person contributed 79,723 common shares and 158,334 restricted shares to Parent in exchange for an equivalent amount of shares of common stock ("Parent Common Shares") and restricted shares, respectively, of Parent, which Parent Common Shares were then exchanged for an equivalent amount of interests in Stallion Group Parent, LP.
Signature
/s/ John F. Duggan, Attorney-in-Fact|2026-07-01